Cargando…
SLC1A3 contributes to L‐asparaginase resistance in solid tumors
L‐asparaginase (ASNase) serves as an effective drug for adolescent acute lymphoblastic leukemia. However, many clinical trials indicated severe ASNase toxicity in patients with solid tumors, with resistant mechanisms not well understood. Here, we took a functional genetic approach and identified SLC...
Autores principales: | Sun, Jianhui, Nagel, Remco, Zaal, Esther A, Ugalde, Alejandro Piñeiro, Han, Ruiqi, Proost, Natalie, Song, Ji‐Ying, Pataskar, Abhijeet, Burylo, Artur, Fu, Haigen, Poelarends, Gerrit J, van de Ven, Marieke, van Tellingen, Olaf, Berkers, Celia R, Agami, Reuven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826201/ https://www.ncbi.nlm.nih.gov/pubmed/31523835 http://dx.doi.org/10.15252/embj.2019102147 |
Ejemplares similares
-
Boosting Antitumor Immunity with an Expanded Neoepitope Landscape
por: Nagel, Remco, et al.
Publicado: (2022) -
ABPEPserver: a web application for documentation and analysis of substitutants
por: Pataskar, Abhijeet, et al.
Publicado: (2023) -
Suppression of heparan sulfation re-sensitizes YAP1-driven melanoma to MAPK pathway inhibitors
por: Dieter, Sebastian M., et al.
Publicado: (2022) -
Functional CRISPR screen identifies AP1-associated enhancer regulating FOXF1 to modulate oncogene-induced senescence
por: Han, Ruiqi, et al.
Publicado: (2018) -
A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
por: Li, Li, et al.
Publicado: (2021)